Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Report Publication Announcement 2014

Jul 30, 2014

6785_rns_2014-07-30_9b6aa769-0cb3-42c1-a7ca-4dfa36998b97.htm

Report Publication Announcement

Open in viewer

Opens in your device viewer

_________ false

C003����� ��"�2PublicEVOGENE LTD10185Corporation no: 512838723Stock Exchange/Market: -12369381Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: [email protected] via MAGNA: 30/07/2014              Time of broadcast: 14:02 12:46:56

Company site: www.evogene.com

Reference: 2014-02-123567

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on Press Release - Second Quarter 2014 Earnings Announcement Schedule

Evogene_2Q14_Results_CC_Schedule_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 14/05/2014
- - -
Name of the Signatory: : Shalem Merav , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: .
Gad Feinstein St. Telephone: 08-9311900 , Facsimile: 08-9466724 , E-mail: [email protected] 1